About Bluejay Diagnostics Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://bluejaydx.com/
Frequently Asked Questions
What is the 52-week range for BJDX?
The 52-week high is $16.68 and the 52-week low is $0.8002.
What is the P/E ratio for BJDX?
The P/E ratio data is currently unavailable.
What is the dividend yield for BJDX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -125.01%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.20.
Analyst Recommendation Trends
Wall Street analyst consensus for BJDX over the last few months:
Latest BJDX News
Top movers analysis one hour before the close of the markets on 2026-09-08: top gainers and losers in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Top movers analysis in the middle of the day on 2026-09-08: top gainers and losers in today's session.
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance
The Lovell Government Services agreement establishes federal procurement infrastructure for the Symphony platform, but commercialization remains dependent on regulatory authorization. Key Investor TakeawaysBluejay Diagnostics (NASDAQ:BJDX) has formed a distribution, co-marketing and strategic partnership with Lovell Government Services targeting U.
There are notable gap-ups and gap-downs in today's session.
The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's regular session. The market value of their outstanding shares is at $162.5 million. PDS Biotechnology (NASDAQ:PDSB)
These stocks are moving in today's pre-market session
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Partnership Establishes Federal Distribution and Co-Marketing Framework Across VA, DoD, Military Health Systems and Other Government Healthcare ChannelsACTON, Mass. and PENSACOLA, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes through its Symphony™ near-patient diagnostic platform, and Lovell Government Services, Inc. (“Lovell”), a Service-Disabled Veteran-Owned Co
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by
Bluejay Diagnostics And Lovell Announce Distribution, Co-Marketing And Strategic Partnership To Support Introduction Of Bluejay’s Products Into U.S. Federal Healthcare Market
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes through its Symphony™ near-patient diagnostic platform, and
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-17 | ZEIDMAN FRED S | +100,000 | - | - |
| 2026-08-17 | Wurth Douglas Clark | +100,000 | - | - |
| 2026-08-17 | Dey Svetlana | +100,000 | - | - |
| 2026-08-17 | Dey Indranil | +28,000 | - | - |
| 2026-08-17 | CHASE DONALD R | +100,000 | - | - |
| 2026-07-10 | HRT FINANCIAL LP | -34,938 | $1.4 | $48,913 |
| 2026-07-09 | HRT FINANCIAL LP | +64,047 | $1.51 | $96,711 |
| 2026-03-14 | Wurth Douglas Clark | +12,500 | $2 | $25,000 |
| 2026-03-14 | Dey Indranil | +12,500 | $2 | $25,000 |
| 2026-03-14 | ZEIDMAN FRED S | +12,500 | $2 | $25,000 |
| 2026-03-14 | Dey Svetlana | +12,500 | $2 | $25,000 |
| 2026-03-14 | CHASE DONALD R | +12,500 | $2 | $25,000 |